Portola Pharmaceuticals Inc Revenue per Employee (PTLA), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Portola Pharmaceuticals inc   (NASDAQ: PTLA)
 

Portola Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 19.04% in the first quarter 2020, year on year to cumulative value of $121 million, Portola Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 341,412, this marks a new company high.
Within the Healthcare sector Employees of 114 other companies have achieved higher revenue per employee. While Portola Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1553. Portola Pharmaceuticals Inc has 354 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTLA Revenue per Employee (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter
Y / Y Revenue Change 19.04 % 91.19 % 159.57 % 608.65 % 233.67 %
Sales per Employee (TTM) $ 341,412 329,492 290,085 226,181 157,218
PTLA's Total Ranking # 1553 # 0 # 0 # 0 # 0
Seq. Revenue Change -9.78 % -20.52 % 29.46 % 28.22 % 44.91 %

PTLA Company Profile >> Back to PTLA Efficiency Comparisons >> Compare PTLA Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 68
Healthcare Sector # 115
Overall Market # 1553

Revenue per Employee Statistics
High Average Low
$ 341,412 $ 111,043 $ 27,068
(Mar 31 2020)   (June 30. 2015)



Financial Statements
Portola Pharmaceuticals Inc 's Revenue MRQ $ 26 Millions Visit PTLA's Income Statement
Portola Pharmaceuticals Inc 's Revenues TTM $ 121 Millions Visit PTLA's aggregate revenue growth
What are PTLA's Sales? Visit PTLA's Sales by Segment




Other Ratios
Portola Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PTLA's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PTLA's Competitors
Revenue per Employee for PTLA's Suppliers
Revenue per Employee for PTLA's Customers

You may also want to know
PTLA's Sales Growth Rates PTLA's Pe Price to earnings ratio PTLA's Receivables Turnover Ratio PTLA's Stock Quote
PTLA's Net Income Growth Rates PTLA's Ps Price to Sales ratio PTLA's Sales per Employee PTLA's Asset Turnover Ratio
PTLA's Net Margin PTLA's Pb Price to Book ratio PTLA's Financial Strength Ratios PTLA's Dividend Payout Ratio
Date modified: 2026-08-29T17:19:42+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2020, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2020Number of Employees Mar 31 2020
Nextcure Inc   594,500.00 $ 23.780  Million 40 
Rigel Pharmaceuticals Inc  588,649.43 $ 102.425  Million 174 
Johnson and Johnson  587,563.92 $ 82,729.000  Million 140,800 
Alkermes Plc   582,470.73 $ 1,194.065  Million 2,050 
Biomarin Pharmaceutical Inc  560,500.47 $ 1,805.372  Million 3,221 
Fortress Biotech Inc   552,179.49 $ 43.070  Million 78 
Milestone Scientific Inc   551,331.87 $ 8.270  Million 15 
Seres Therapeutics Inc   535,954.55 $ 35.373  Million 66 
Pediatrix Medical Group Inc   535,206.25 $ 3,508.277  Million 6,555 
3m Company  534,677.69 $ 32,348.000  Million 60,500 
Pacira Biosciences inc   525,207.48 $ 435.397  Million 829 
Cardiovascular Systems Inc   524,466.00 $ 262.233  Million 500 
Regeneron Pharmaceuticals Inc   517,832.58 $ 7,979.800  Million 15,410 
Logicmark Inc  506,049.09 $ 16.700  Million 33 
Accuray Incorporated  501,072.93 $ 405.368  Million 809 
Teva Pharmaceutical Industries Limited  499,234.17 $ 16,949.000  Million 33,950 
Prophase Labs Inc   497,157.89 $ 9.446  Million 19 
Kaya Holdings Inc   492,909.50 $ 0.986  Million 2 
Wearable Health Solutions, Inc.  490,100.00 $ 0.980  Million 2 
Healthlynked Corp  489,076.80 $ 4.891  Million 10 
Sarepta Therapeutics Inc   488,019.16 $ 407.496  Million 835 
Spero Therapeutics Inc   485,200.00 $ 12.130  Million 25 
Mylan N v   484,891.43 $ 16,971.200  Million 35,000 
Adamas Pharmaceuticals Inc  478,775.00 $ 57.453  Million 120 
Inogen Inc   478,393.09 $ 360.230  Million 753 
Icad Inc  477,545.45 $ 31.518  Million 66 
Cerus Corporation  476,840.28 $ 137.330  Million 288 
Hologic Inc  470,268.74 $ 3,324.800  Million 7,070 
Durect Corp  462,426.23 $ 28.208  Million 61 
Eli Lilly And Company  461,742.00 $ 23,087.100  Million 50,000 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.